Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-288-3 | CAS number: 137-30-4
Carcinogenicity
Administrative data
Description of key information
Ziram is not carcinogenic in mice or rats
Key value for chemical safety assessment
Carcinogenicity: via oral route
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 34.6 mg/kg bw/day
Additional information
At 24 mg/kg bw/d, male rats showed treatment-related haemangiomata in mesenteric lymph nodes and spleen. These haemangiomata were not pronounced, did not show evidence of malignancy and were confined to this group and sex only.
In mice, ziram did not induce tumours at dose levels up to 82 mg/kg bw for 80 weeks. In all treated groups, increased incidences of centrilobular and/or generalised hepatocellular enlargement were seen. Urinary bladder epithelial hyperplasia was observed in males and females receiving 82 mg/kg bw and in males receiving 27 mg/kg bw.
The NOAEL was lower than 3 mg/kg bw/d. Pulmonary tumours, found in one study, occurred in the presence of a virus
Carcinogenicity: via oral route (target organ): cardiovascular / hematological: other
Justification for classification or non-classification
No treatment-related and toxicologically significant tumours were detected in rats or mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Route: .live1